Implantable cardioverter defibrillator electrogram adjudication for device registries: Methodology and observations from ALTITUDE

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 8, 2011, Pages 1003-1012

  Powell, Brian D ^a   Cha, Yong Mei ^a   Asirvatham, Samuel J ^a   Cesario, David A ^b   Cao, Michael ^b   Jones, Paul W ^c   Seth, Milan ^c   Saxon, Leslie A ^b   Gilliam Iii, F Roosevelt ^d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Boston Scientific   (United States)

^d Cardiology Associates of NE Arkansas ^*  (United States)

Author keywords

ambulatory arrhythmias; cardiac methods; database management systems monitoring; defibrillators; implantable cardiac resynchronization therapy

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; ELECTROGRAPHY; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; LATITUDE SYSTEM; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MULTICENTER STUDY; NONSUSTAINED ARRHYTHMIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PEER REVIEW; POLYMORPHIC AND MONOMORPHIC VENTRICULAR TACHYCARDIA; REMOTE SENSING; REVIEW; SINUS RHYTHM; SINUS TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; UNITED STATES;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MONITORING, PHYSIOLOGIC; REGISTRIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 80051695712     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03093.x     Document Type: Review

References (19)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
4. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al,. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDS): Description of techniques, indications, personnel, frequency and ethical considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 2008; 10: 707-725.
5. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, et al,. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up. Circulation 2010; 122: 2359-2367.
6. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, et al,. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001; 12: 134-142. (Pubitemid 32171500)
7. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, et al,. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study. Circulation 2006; 113: 2871-2879. (Pubitemid 44297227)
8. Grimm W, Flores BF, Marchlinski FE,. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992; 15: 1667-1673.
9. Kuhlkamp V, Dornberger V, Mewis C, Suchalla R, Bosch RF, Seipel L,. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999; 10: 905-915. (Pubitemid 29297709)
10. Schmitt C, Montero M, Melichercik J,. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 1994; 17: 295-302. (Pubitemid 24092111)
11. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ,. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004; 44: 2362-2367. (Pubitemid 39647611)
12. Theuns DA, Klootwijk AP, Simoons ML, Jordaens LJ,. Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. Am J Cardiol 2005; 95: 271-274. (Pubitemid 40092100)
13. Mitka M,. New study supports lifesaving benefits of implantable defibrillation devices. JAMA 2009; 302: 134-135.
14. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al,. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: e247-e346. (Pubitemid 44382683)
15. Viera AJ, Garrett JM,. Understanding inter-observer agreement: The Kappa statistic. Fam Med 2005; 37: 360-363. (Pubitemid 40656185)
16. Conger AJ,. Integration and geralisation of kappas for multiple raters. Psychol Bull 1980; 88: 322-328.
17. Cohen J,. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37-46.
18. McClelland RL, Bamlet WR, Glikson M, Friedman PA,. Design and analysis issues in cardiac arrhythmia trials: Insights from the detect supraventricular tachycardia trial. Clin Trials 2007; 4: 74-80.
19. Sinha AM, Stellbrink C, Schuchert A, Mox B, Jordaens L, Lamaison D, Gill J, et al,. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 2004; 15: 646-652. (Pubitemid 38757168)